Rapid detection of equine herpesvirus type-1 antigens in nasal swab specimens using an antigen capture enzyme-linked immunosorbent assay

• Published in: Journal of virological methods Vol. 39; no. 3; pp. 299 - 310
• Main Authors: Sinclair, R., Mumford, J.A.
• Format: Journal Article
• Language: English
• Published: London Elsevier B.V 01.09.1992; Amsterdam Elsevier; New York, NY
• Subjects: Animals; Antibodies, Monoclonal; Antibodies, Viral; ANTICORPS MONOCLONAL; ANTICUERPOS MONOCLONALES; ANTIGENE; ANTIGENOS; ANTIGENS; Antigens, Viral - analysis; Biological and medical sciences; ELISA; Enzyme-Linked Immunosorbent Assay - methods; Equid herpesvirus type-1; EQUINE HERPESVIRUS; Fundamental and applied biological sciences. Psychology; Herpesviridae Infections - diagnosis; Herpesviridae Infections - veterinary; Herpesvirus 1, Equid - immunology; Herpesvirus 1, Equid - isolation & purification; HERPESVIRUS EQUIN; HERPESVIRUS EQUINO; Horse Diseases - diagnosis; Horse Diseases - immunology; Horses; Mice; Mice, Inbred BALB C; Microbiology; MONOCLONAL ANTIBODIES; Nasal Cavity - microbiology; Nasal swab; PONEY; PONIES; Rapid diagnosis; Species Specificity; TEST ELISA; Virology; Rapid diagnosis; Nasal swab; Equid herpesvirus type-1; ELISA; Virus; Antigen; Equine herpesvirus 1; Herpesviridae; Alphaherpesvirinae; Detection; ELISA assay
• ISSN: 0166-0934; 1879-0984
• DOI: 10.1016/0166-0934(92)90103-K

An antigen capture enzyme-linked immunosorbent assay (ELISA) was developed for the detection of equine herpesvirus type-1 (EHV-1) antigens in nasal swab specimens. The test was designed as a solid phase, amplified sandwich assay in which an EHV-1 specific monoclonal antibody was used to capture virus antigen and polyclonal antisera used to detect antigen bound to the test plates. Eight monoclonal antibodies were tested for their ability to capture virus antigen and one was selected for routine use. The sensitivity and specificity of the ELISA was compared with that of virus isolation using swabs from ponies which were experimentally infected with EHV-1. Of 72 nasal swabs collected, 32 were found to be positive by both virus isolation (VI) and ELISA, a further 15 samples were positive by VI alone, but none of the samples were positive by ELISA and negative by VI. This yielded an overall assay sensitivity of 68% and specificity of 100%. The assay proved useful for diagnosis since virus antigen was detected during the first four days post-infection which corresponded to the acute phase of disease when some clinical symptoms were apparent. In addition, the assay could be completed within one day when antibody coated plates were available.